MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

06 May 2022 Evaluate
The sales figure stood at Rs. 205.58 millions for the March 2022 quarter. The mentioned figure indicates a growth of about 33.75% as compared to Rs. 153.70 millions during the year-ago period.Good  Net Profit growth of 26.74% reported above the corresponding previous quarter figure of Rs. 30.29 millions to Rs. 38.39 millioins.The company reported a good operating profit of 57.83 millions compared to 52.39 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 205.58 153.70 33.75 712.88 490.82 45.24 712.88 490.82 45.24
Other Income 11.37 1.53 643.14 35.68 20.95 70.31 35.68 20.95 70.31
PBIDT 57.83 52.39 10.38 214.88 157.42 36.50 214.88 157.42 36.50
Interest 0.15 0.14 7.14 1.46 0.68 114.71 1.46 0.68 114.71
PBDT 57.68 52.25 10.39 213.42 156.74 36.16 213.42 156.74 36.16
Depreciation 5.80 11.84 -51.01 33.37 27.25 22.46 33.37 27.25 22.46
PBT 51.88 40.41 28.38 180.05 129.49 39.05 180.05 129.49 39.05
TAX 13.49 10.12 33.30 46.07 31.96 44.15 46.07 31.96 44.15
Deferred Tax -0.03 -3.18 -99.06 -0.39 -0.36 8.33 -0.39 -0.36 8.33
PAT 38.39 30.29 26.74 133.98 97.53 37.37 133.98 97.53 37.37
Equity 120.08 100.06 20.01 120.08 100.06 20.01 120.08 100.06 20.01
PBIDTM(%) 28.13 34.09 -17.47 30.14 32.07 -6.02 30.14 32.07 -6.02
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..